Related Experiment Video
Updated: Jun 13, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Epidemiological features of type 2 diabetes]
1Service de diabétologie, groupe hospitalier Pitié-Salpêtrière, AP-HP, 75013 Paris. dominique.simon@psl.aphp.fr
La Revue Du Praticien
|May 15, 2010
Summary
Type 2 diabetes (T2D) is a growing global health crisis, projected to affect 300 million people by 2025. Rising obesity and aging populations are key drivers, necessitating population-level lifestyle changes for prevention.
Area of Science:
- Endocrinology
- Public Health
- Epidemiology
Background:
- Type 2 diabetes (T2D) accounts for over 90% of all diabetes cases globally.
- The global prevalence of T2D in adults was 4.0% in 1995 and projected to reach 5.4% by 2025.
- Estimates suggest the number of diabetic patients will rise from 135 million in 1995 to 300 million by 2025.
Purpose of the Study:
- To highlight the escalating global prevalence of Type 2 Diabetes.
- To identify key contributing factors to the diabetes epidemic.
- To emphasize the need for population-level prevention strategies.
Main Methods:
- Analysis of global diabetes prevalence data from 1995 to projected 2025.
- Examination of demographic trends, including population aging.
- Consideration of the impact of obesity on diabetes prevalence.
Main Results:
- T2D prevalence is expected to increase significantly, with 300 million cases by 2025.
- Developing countries, particularly India and China, will bear a disproportionate increase in cases.
- Obesity and population aging are identified as primary drivers of the diabetes epidemic.
- In France, pharmacologically treated diabetes prevalence was 3.95% in 2007, with 92% being T2D.
Conclusions:
- The rise in Type 2 Diabetes is a significant global health concern.
- Urgent, population-wide lifestyle modifications are crucial for T2D prevention.
- Addressing obesity and demographic shifts is essential to curb the diabetes epidemic.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...